[HTML][HTML] Ebola virus disease
ST Jacob, I Crozier, WA Fischer, A Hewlett… - Nature reviews Disease …, 2020 - nature.com
Ebola virus disease (EVD) is a severe and frequently lethal disease caused by Ebola virus
(EBOV). EVD outbreaks typically start from a single case of probable zoonotic transmission …
(EBOV). EVD outbreaks typically start from a single case of probable zoonotic transmission …
[HTML][HTML] The role of PD-1 in acute and chronic infection
JM Jubel, ZR Barbati, C Burger, DC Wirtz… - Frontiers in …, 2020 - frontiersin.org
PD-1 as an immune checkpoint molecule down-regulates T cell activity during immune
responses in order to prevent autoimmune tissue damage. In chronic infections or tumors …
responses in order to prevent autoimmune tissue damage. In chronic infections or tumors …
Blood molecular markers associated with COVID‐19 immunopathology and multi‐organ damage
YM Chen, Y Zheng, Y Yu, Y Wang, Q Huang… - The EMBO …, 2020 - embopress.org
COVID‐19 is characterized by dysregulated immune responses, metabolic dysfunction and
adverse effects on the function of multiple organs. To understand host responses to COVID …
adverse effects on the function of multiple organs. To understand host responses to COVID …
[HTML][HTML] Integrated immune dynamics define correlates of COVID-19 severity and antibody responses
SARS-CoV-2 causes a spectrum of COVID-19 disease, the immunological basis of which
remains ill defined. We analyzed 85 SARS-CoV-2-infected individuals at acute and/or …
remains ill defined. We analyzed 85 SARS-CoV-2-infected individuals at acute and/or …
[HTML][HTML] The PD-1/PD-L1 axis and virus infections: a delicate balance
G Schönrich, MJ Raftery - Frontiers in cellular and infection …, 2019 - frontiersin.org
Programmed cell death protein (PD-1) and its ligands play a fundamental role in the evasion
of tumor cells from antitumor immunity. Less well appreciated is the fact that the PD-1/PD-L1 …
of tumor cells from antitumor immunity. Less well appreciated is the fact that the PD-1/PD-L1 …
[HTML][HTML] Lymphopenia caused by virus infections and the mechanisms beyond
Z Guo, Z Zhang, M Prajapati, Y Li - Viruses, 2021 - mdpi.com
Viral infections can give rise to a systemic decrease in the total number of lymphocytes in the
blood, referred to as lymphopenia. Lymphopenia may affect the host adaptive immune …
blood, referred to as lymphopenia. Lymphopenia may affect the host adaptive immune …
Dysregulated IFN-γ signals promote autoimmunity in STAT1 gain-of-function syndrome
AD Largent, K Lambert, K Chiang, N Shumlak… - Science Translational …, 2023 - science.org
Heterozygous signal transducer and activator of transcription 1 (STAT1) gain-of-function
(GOF) mutations promote a clinical syndrome of immune dysregulation characterized by …
(GOF) mutations promote a clinical syndrome of immune dysregulation characterized by …
[HTML][HTML] Longitudinal analysis of the human B cell response to Ebola virus infection
Ebola virus (EBOV) remains a public health threat. We performed a longitudinal study of B
cell responses to EBOV in four survivors of the 2014 West African outbreak. Infection …
cell responses to EBOV in four survivors of the 2014 West African outbreak. Infection …
[HTML][HTML] Ebola virus disease: An emerging and re-emerging viral threat
The genus Ebolavirus from the family Filoviridae is composed of five species including
Sudan ebolavirus, Reston ebolavirus, Bundibugyo ebolavirus, Taï Forest ebolavirus, and …
Sudan ebolavirus, Reston ebolavirus, Bundibugyo ebolavirus, Taï Forest ebolavirus, and …
[HTML][HTML] Transcriptomic signatures differentiate survival from fatal outcomes in humans infected with Ebola virus
X Liu, E Speranza, C Muñoz-Fontela, S Haldenby… - Genome biology, 2017 - Springer
Abstract Background In 2014, Western Africa experienced an unanticipated explosion of
Ebola virus infections. What distinguishes fatal from non-fatal outcomes remains largely …
Ebola virus infections. What distinguishes fatal from non-fatal outcomes remains largely …